Uniwersytet Medyczny W Lodzi
- Address
- Al. Tadeusza Kosciuszki 4, 90-419 Lodz, Poland
Uniwersytet Medyczny w Lodzi - Advanced Clinical Research Center
The Medical University of Lodz operates as a prominent clinical research institution conducting diverse therapeutic trials across multiple medical specialties. The center demonstrates particular expertise in nephrology, immunology, rheumatology, and pediatric oncology, with a strong emphasis on innovative treatment approaches for complex and rare diseases.
- Renal disease management and anemia treatment in chronic kidney disease patients undergoing dialysis
- Autoimmune disorders including presymptomatic type 1 diabetes and systemic sclerosis with interstitial lung disease
- Pediatric oncology with focus on high-grade glioma treatment optimization
- Advanced cellular therapies and combination immunotherapies for disease modification
The research center specializes in evaluating novel therapeutic agents and combination regimens, including erythropoiesis-stimulating agents for renal anemia, regulatory T-cell therapy combined with monoclonal antibodies for early-stage diabetes intervention, and targeted therapies such as nintedanib and tocilizumab for systemic sclerosis-associated lung disease. Their pediatric research program investigates rapamycin safety and efficacy in challenging conditions like high-grade gliomas, demonstrating commitment to addressing unmet medical needs across all age groups.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Genexine Inc.2active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Genexine Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Uniwersytet Medyczny W Lodzi
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Efepoetin Alfa Versus Darbepoetin Alfa in Anemia Management for Chronic Kidney Disease Patients on Dialysis | Genexine Inc. | Phase III | Recruiting | Jul 2025 | — |
IMP list
lock Showing 1 of 12 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Darbepoetin Alfa | 2 | Unknown | 2025-07-22 | 2025-07-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.